Triglyceride-glucose index is a risk factor for breast cancer in China: a cross-sectional study

• Published in: Lipids in health and disease Vol. 23; no. 1; pp. 29 - 9
• Main Authors: Zhang, Jinghua, Yin, Binbin, Xi, Ya, Bai, Yongying
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 26-01-2024; BioMed Central; BMC
• Subjects: Age; Analysis; Benign breast disease; Biological markers; Biomarker; Biomarkers; Birth control; Blood Glucose; Body mass index; Breast cancer; Breast diseases; Breast Neoplasms - diagnosis; Breast Neoplasms - epidemiology; Cancer therapies; Care and treatment; China - epidemiology; Cholesterol; Cross-Sectional Studies; Demographic aspects; Family medical history; Female; Glucose; Health aspects; High density lipoprotein; Hospitals; Humans; Hypertension; Information systems; Insulin resistance; Measurement; Medical screening; Prevention; Regression analysis; Risk; Risk Factors; Triglyceride-glucose index; Triglycerides; China; United States > US; Triglyceride-glucose index; Insulin resistance; Risk; Biomarker; Breast cancer; Benign breast disease
• ISSN: 1476-511X; 1476-511X
• DOI: 10.1186/s12944-024-02008-0

This research delved into the association between the risk of the Chinese population suffering from breast cancer (BC) and the triglyceride-glucose (TyG) index.
A total of 2,111 sufferers with benign breast disease (BBD) and 477 sufferers with BC were enrolled, and their TyG index was measured. Participants with varying TyG index values were categorized into quartiles. Logistic regression analysis was employed to assess the relationship between the TyG index and BC risk. The diagnostic performance of the TyG index for different stages of BC was measured using the receiver operating characteristic (ROC) curve.
The TyG index of BC sufferers exceeded that of BBD (P < 0.001). A continuous increase in the risk of BC was found to be positively correlated with an ever-increasing TyG index. In the unadjusted model, the risk of getting BC mounted with quartiles of the TyG index growing (P < 0.001). In a logistic regression analysis that included all confounders, the highest quartile of the TyG index was strongly linked to BC risk [1.43 (1.01, 2.02), P < 0.05]. Moreover, with the adjustment of potential confounders, a high TyG index was found to result in a 2.53-fold higher risk of being diagnosed with advanced BC.
The risen TyG index was positively correlated to the heightening risk of BC and had the potential to serve as a promising biomarker for BC. Individuals with a high TyG index ought to be mindful of the heightened risk of BC onset and progression.